Skip to main content
TipRanks
Go Ultimate75% OFF

Alan Hulme Insider Profile

4 Followers

Alan Hulme, Director at Oncopeptides AB, holds 280.50K shares in Oncopeptides AB (Ticker: SE:ONCO). Most recently, Alan Hulme Bought 2,400 shares of Oncopeptides AB on Mar 01, 2017 for an estimated value of kr104.40K.

Alan Hulme's Trading History

ONCO
Oncopeptides AB
Mar 01, 2017DirectorInformative Buy104.40Kkr496.77K
SE:ONCO
Insider Shares: 280.50K (0.00%)
DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
Mar 01, 2017Informative Buykr104.40K2,400kr43.50+75.40%―
Feb 28, 2017Informative Buykr1.00M21,740kr46.00+80.60%―
Feb 28, 2017Uninformative Buykr972.99K21,152kr46.00――

You May Also Like

Alan Hulme insider profile FAQ

What is the percentage of profitable transactions made by Alan Hulme?
The percentage of profitable transactions made by Alan Hulme is 100%.
What is the average return per transaction made by Alan Hulme?
The average return per transaction made by Alan Hulme is 78.00%.
What stocks does Alan Hulme hold?
Alan Hulme holds: SE:ONCO stocks.
What was Alan Hulme’s latest transaction?
Alan Hulme’s latest transaction was an Informative Buy of kr104.40K.
What was Alan Hulme's most profitable transaction?
Alan Hulme’s most profitable transaction was an Informative Buy of SE:ONCO stock on February 28, 2017. The return on the trade was 80.60%.
What is Alan Hulme's role in Oncopeptides AB?
Alan Hulme's role in Oncopeptides AB is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.